Clearance of spontaneous gastroesophageal reflux in awake and sleeping infants

J M Sondheimer1

  • 1Department of Pediatrics, University of Colorado Health Sciences Center, Denver.

Gastroenterology
|October 1, 1989
PubMed

Insights

Infants with pathologic gastroesophageal reflux have significantly delayed acid clearance during sleep. This is linked to a lower swallowing rate during sleep, not differences in reflux events or esophageal function.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Motility Disorders
  • Infant Health

Background:

  • Gastroesophageal reflux (GER) is common in infants.
  • Pathologic GER can lead to significant health issues.
  • Understanding acid clearance mechanisms is crucial for infant GER management.

Purpose of the Study:

  • To compare esophageal acid clearance times in infants with and without pathologic GER.
  • To investigate factors contributing to delayed acid clearance during sleep.

Main Methods:

  • Continuous monitoring of distal esophageal pH and pharyngeal/esophageal manometry in 30 infants (<12 months).
  • Comparison of acid clearance times during awake and asleep reflux episodes.
  • Analysis of swallowing rate, peristalsis, and secondary waves.

Main Results:

  • Acid clearance times were similar when awake.
  • Asleep, infants with pathologic GER showed >500% increase in acid clearance time.
  • Significantly lower swallowing rates (0.5/min vs 3.5/min) during sleep in pathologic GER infants.

Conclusions:

  • Low swallowing rate during sleep is the primary cause of delayed acid clearance in infants with pathologic GER.
  • Findings highlight the importance of swallowing frequency in managing infant reflux.
  • Further research into sleep-related swallowing patterns is warranted.

Related Concept Videos

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...